July 14, 2020
HOYA Vision Care Canada launched MiYOSMART lenses with D.I.M.S. Technology in Canada on July 1st, 2020. Following years of academic studies, product design and clinical research, HOYA and The Hong Kong Polytechnic University developed a spectacle lens1 based on Defocus Incorporated Multiple Segments Technology or “D.I.M.S. Technology” that won the Grand Prize, Grand Award and Gold Medal at the 46th International Exhibition of Inventions of Geneva in April 2018.2
Wearing defocus spectacle lenses daily significantly slows myopia progression and axial elongation in myopic children aged 8 to 13, according to a two-year double-blind randomized clinical trial conducted in Hong Kong.3 The trial concluded that children wearing defocus lenses had 60 percent less myopia progression compared with those wearing single vision lenses.4 These findings provide strong evidence that defocus lenses are effective in reducing myopia progression.
“This is the myopia management option that the Canadian market has been waiting for, and we are proud to provide such an effective treatment with award-winning technology that emphasizes Hoya’s leadership in the optical industry,” said Ahmos Henry, president of HOYA Vision Care Canada.
MiYOSMART lenses are an effective non-invasive method to manage myopia which can be fitted to a myopic child at any age like regular single vision lenses. MiYOSMART´s efficacy is based on patent-protected D.I.M.S segments (islands) creating a myopic defocus effect. They feature a low-maintenance multicoating that is water repellant, easy to wipe and durable with UV protection, making it suitable for children.
Eye care professionals who plan to dispense MiYOSMART lenses will be required to complete an essential certification program ensuring a comprehensive understanding of the technology and recommended fitting protocols that will be made available immediately.
MiYOSMART lenses will not be available in the United States at this time.